CEO Reshma Kewalramani highlighted the company’s strong performance in Q1 2025, with $2.77 billion in revenue, representing a 3% year-over-year increase. Growth was driven by expanding patient reach ...

Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company ...

Vertex Pharmaceuticals missed Wall Street estimates for quarterly results on Monday, due to lower-than-expected sales of its ...

Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York.

Power and GPU scarcity continues to be center stage. Executives repeated the phrase “critical‑path” when discussing megawatt ...

The Board of Directors of CDG Petchem Limited, at its meeting held today have approved the financial results of the company ...

Retailers across the UK are working with limited stock and high demand. Our Switch 2 stock tracker liveblog is here to help. If you’re an existing Switch Online member with at least a year of ...

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 2.37% to $477.52 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 2.36% ...

Are you rich? Here’s what Americans think you need to be considered wealthy. The 52-week range of Verizon stock price was $37.59 to $47.36. Verizon's dividend yield is 6.12%. It paid $2.71 per ...